BamSEC and AlphaSense Join Forces
Learn More

Lyra Therapeutics Inc. – Material Contracts

OTC: LYRA    
Share price (7/17/26): $0.52    
Market cap (7/17/26): $923 thousand
Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.4
from 10-Q 4 pages Second Amendment to the Employment Agreement Between Lyra Therapeutics, Inc. and Maria Palasis
12/34/56
EX-10.3
from 10-Q 4 pages First Amendment to the Employment Agreement Between Lyra Therapeutics, Inc. and Jason Cavalier
12/34/56
EX-10.2
from 10-Q 4 pages First Amendment to the Employment Agreement Between Lyra Therapeutics, Inc. and Harlan Waksal
12/34/56
EX-10.1
from 10-Q 29 pages Securities Purchase Agreement
12/34/56
EX-10.1
from 8-K 45 pages Securities Purchase Agreement
12/34/56
EX-10.28
from 10-K 6 pages Novation Agreement
12/34/56
EX-10.2
from 10-Q 5 pages Lyra Therapeutics, Inc. 2020 Incentive Award Plan Performance Stock Option Grant Notice
12/34/56
EX-10.1
from 10-Q 6 pages Lyra Therapeutics, Inc. 2020 Incentive Award Plan Performance Based Restricted Stock Unit Grant Notice
12/34/56
EX-10.24
from 10-K 15 pages Premises: Sublessor Hereby Subleases to Sublessee, and Sublessee Hereby Subleases From Sublessor, Approximately 23,704 Rentable Square Feet (Rsf) of the Master Premises on the First Floor of the Building as Shown on the Floorplan Attached to This Sublease as Exhibit B (The “Premises”), for the Term (As Hereinafter Defined) and Upon the Terms and Conditions Set Forth in This Sublease. Sublessor Hereby Grants and Assigns to Sublessee All of Sublessor’s Rights to Use the Common Areas, the Common Facilities, and the On-Site Generator During the Term in Accordance With the Terms and Provisions of the Master Lease. 3. Term: A
12/34/56
EX-10.1
from 10-Q 2 pages Amendment No. 1 to Lyra Therapeutics, Inc. 2022 Employment Inducement Award Plan, as Amended and Restated Effective December 12, 2022
12/34/56
EX-10.1
from 8-K 5 pages Seventh Amendment to Lease
12/34/56
EX-10.2
from 8-K 36 pages Registration Rights Agreement
12/34/56
EX-10.1
from 8-K 95 pages Securities Purchase Agreement
12/34/56
EX-10
from 10-K 7 pages March 3, 2023 via Email Lyra Therapeutics, Inc. 480 Arsenal Way Watertown, Ma 02472 Email: Lpham@lyratx.com Re
12/34/56
EX-10
from 10-K 20 pages Employment Agreement
12/34/56
EX-10
from 10-K 17 pages Lyra Therapeutics, Inc. 2022 Employment Inducement Award Plan as Amended and Restated Effective December 12, 2022
12/34/56
EX-10.1
from 8-K 5 pages Sixth Amendment to Lease
12/34/56
EX-10.2
from 10-Q 2 pages Amendment No. 3 to Lyra Therapeutics, Inc. 2022 Employment Inducement Award Plan
12/34/56
EX-10.1
from 10-Q 6 pages Introduction
12/34/56
EX-10.3
from 10-Q 18 pages Employment Agreement
12/34/56